-
Notice of CDE of China NMPA on Issuing the Technical Requirements for CMC Study and Evaluation of Chemical Drugs Marketed Overseas But Not Marketed in China (Interim)
2021-03-09
The CDE, under the guidance of NMPA, has organized to formulate the Technical Requirements for CMC Study and Evaluation of Chemical Drugs Marketed Overseas But Not Marketed in China (Interim), which was issued and implemented as of March 3.
-
The State Council's Leading Group for Deepening the Reform of the Medical and Health System Issued the Notice on Policies and Measures to Further Deepen the Reform of the Medical and Health System with Centralized Procurement & Use of Drugs as a Breakthrough
2019-12-02
The Notice pointed out that it is necessary to promote the interlocked reform of health care, health insurance, and pharmaceuticals, magnify the effects of reform, and better address the problems complicating medical services to the people.
-
NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions
2019-11-29
NMPA has formulated,in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China
2019-11-29
NMPA issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China (2019 No. 103).
-
NMPA Issued the Technical Guidelines for Aluminum-Adjuvant-containing Preventive Vaccines
2019-12-10
NMPA has organized the formulation of the Technical Guidelines for Aluminum-Adjuvant-containing Preventive Vaccines, which has been released on December 10, 2019.
-
NMPA Issued the Announcement on Enabling the New Version of Management System for Import Filing of Drugs and Medicinal Materials
2019-12-19
NMPA and the General Administration of Customs have collaboratively established a management system for import filing of pharmaceuticals and medicinal material imports.
